Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial
publié dans: BMJ Open
date de publication: 2019-07-03
sujet principal: essai clinique phase 1, study protocol
Articles cités 18
- 2019-07-01
Date
Titre
Article - wd:Q91620204